In anaplastic thyroid cancer (ATC), Boufraqech et al. reported that miR-30a interacts with the 3′UTR of LOX to mediate anti-tumor efficacy, as evidenced by suppressing cell invasion and migration, EMT markers expression, LOX expression, and metastatic capacity [67]. This evidence concerns the gene LOX and neoplasm.